CIC Events
This activity is part of the CLU-2023-2-01 initiative (Escalera de Excelencia), funded by the Department of Education of the Junta de Castilla y León and the European Regional Development Fund (FEDER)
09/06/2026
In search of the ideal Trojan horse for antitumor treatments
Pilar Martín-Duque — Instituto de Salud Carlos lll, Departamento de Desarrollo de Medicamentos y Terapias Avanzadas (DDMTAs)
25/06/2026
An evolutionary journey across the CLL course
Ferran Nadeu — Fundació Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
02/07/2026
Study of the mechanisms involved in the acquired resistance to the monoclonal antibody isatuximab in multiple myeloma
Marta González Rodríguez — Centro de Investigación del Cáncer (CSIC-USAL-FICUS), Salamanca
Past Events
04/06/2026
The therapeutic targeting of epitranscriptome-associated proteins
Konstantinos Tzelepis — Cambridge Stem Cell Institute, University of Cambridge
28/05/2026
Metabolic crosstalk between the tumour and the host
Karen Vousden — Francis Crick Institute, UK
14/05/2026
Role of the repressor Capicua in KRAS-driven lung tumor development.
Irene Ballesteros González — Centro de Investigación del Cáncer (CSIC, USAL, FICUS)
07/05/2026
Drug-mediated kinase activation: A new type of chemotherapy to target therapy-resistant cancer cells
Óscar Fernández-Capetillo — CNIO-Instituto Karolinska, Sweden